Correlates of protection against rotavirus infection and disease
- PMID: 11444023
- DOI: 10.1002/0470846534.ch8
Correlates of protection against rotavirus infection and disease
Abstract
Repeated infections with the 'mucosal' pathogen rotavirus are common in children. Subsequent rotavirus infections usually cause milder symptoms than first-time infections. Therefore, although natural rotavirus infection attenuates the severity of subsequent infections, it does not prevent reinfection or mild disease. On the other hand, natural infection with 'systemic' viruses such as measles, mumps, rubella, or varicella often confers life-long protection against mild disease associated with reinfection. The degree to which differences in the pathogenesis of systemic and mucosal pathogens determines differences in the capacity of natural infection to induce life-long protective immunity will be discussed. This paradigm will be used to explore the immunological effector functions associated with protection against rotavirus challenge.
Similar articles
-
Protective effects of natural rotavirus infection.Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S54-6. doi: 10.1097/INF.0b013e3181967c03. Pediatr Infect Dis J. 2009. PMID: 19252424 Review.
-
Human immunity to rotavirus.J Med Microbiol. 1995 Dec;43(6):397-404. doi: 10.1099/00222615-43-6-397. J Med Microbiol. 1995. PMID: 7473672 Review.
-
Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children.J Med Virol. 1987 Jan;21(1):39-47. doi: 10.1002/jmv.1890210106. J Med Virol. 1987. PMID: 3025356
-
Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa.J Infect Dis. 2002 Sep 1;186(5):593-7. doi: 10.1086/342294. Epub 2002 Aug 9. J Infect Dis. 2002. PMID: 12195345
-
Rotavirus infection in infants as protection against subsequent infections.N Engl J Med. 1996 Oct 3;335(14):1022-8. doi: 10.1056/NEJM199610033351404. N Engl J Med. 1996. PMID: 8793926
Cited by
-
More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization.Hum Vaccin Immunother. 2018;14(9):2194-2202. doi: 10.1080/21645515.2018.1472185. Epub 2018 Jun 19. Hum Vaccin Immunother. 2018. PMID: 29781755 Free PMC article.
-
CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells.J Clin Invest. 2003 Apr;111(7):1001-10. doi: 10.1172/JCI17244. J Clin Invest. 2003. PMID: 12671049 Free PMC article.
-
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial.Hum Vaccin Immunother. 2023 Aug;19(2):2263228. doi: 10.1080/21645515.2023.2263228. Epub 2023 Oct 16. Hum Vaccin Immunother. 2023. PMID: 37843437 Free PMC article. Clinical Trial.
-
The gastrointestinal frontier: IgA and viruses.Front Immunol. 2013 Nov 28;4:402. doi: 10.3389/fimmu.2013.00402. Front Immunol. 2013. PMID: 24348474 Free PMC article. Review.
-
The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.J Virol. 2004 Jul;78(13):6974-81. doi: 10.1128/JVI.78.13.6974-6981.2004. J Virol. 2004. PMID: 15194774 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical